<p>Oncologists have more innovative methods for treating breast cancer than ever before. In part one of this two-part series, Adam Rutherford and guests explore the hurdles and successes researchers face as they work to develop new, targeted therapies for breast cancer.</p><p>Featured Guests:</p><ul><li>Martha Carlson, Breast Cancer Advocate & Writer</li><li>Dr. Edith Mitchell, Medical Oncologist, Thomas Jefferson University</li><li>Jeff Settleman, Chief Scientific Officer, Pfizer Oncology</li></ul>


<description>&lt;p&gt;Oncologists have more innovative methods for treating breast cancer than ever before. In part one of this two-part series, Adam Rutherford and guests explore the hurdles and successes researchers face as they work to develop new, targeted therapies for breast cancer.&lt;/p&gt;&lt;p&gt;Featured Guests:&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Martha Carlson, Breast Cancer Advocate &amp; Writer&lt;/li&gt;&lt;li&gt;Dr. Edith Mitchell, Medical Oncologist, Thomas Jefferson University&lt;/li&gt;&lt;li&gt;Jeff Settleman, Chief Scientific Officer, Pfizer Oncology&lt;/li&gt;&lt;/ul&gt;
</description>

Oncologists have more innovative methods for treating breast cancer than ever before. In part one of this two-part series, Adam Rutherford and guests explore the hurdles and successes researchers face as they work to develop new, targeted therapies for breast cancer. 

Science Will Win

Part 1: Breast Cancer: The Science, The Challenges, The Solutions

Part 1: Breast Cancer: The Science, The Challenges, The Solutions

Description